Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.19 | 0.17 | 0.18 | 0.27 | 0.34 |
Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 1.40 | 1.74 | 1.89 | 1.70 | 1.60 |
Fixed Assets | 2.08 | 1.42 | 1.82 | 2.46 | 2.30 |
Inventory | 3.28 | 2.26 | 2.75 | 3.44 | 3.21 |
Debtors | 2.55 | 1.98 | 2.28 | 2.70 | 2.43 |
Interest Cover Ratio | 14.46 | 22.67 | 97.66 | 147.20 | 10.74 |
PBIDTM (%) | 27.19 | 22.87 | 18.34 | 29.76 | 23.09 |
PBITM (%) | 24.79 | 19.99 | 14.66 | 26.68 | 19.55 |
PBDTM (%) | 25.47 | 21.98 | 18.19 | 29.58 | 21.27 |
CPM (%) | 20.75 | 17.39 | 16.57 | 22.76 | 17.58 |
APATM (%) | 18.36 | 14.51 | 12.89 | 19.67 | 14.04 |
ROCE (%) | 11.74 | 8.18 | 8.49 | 22.94 | 15.97 |
RONW (%) | 10.35 | 6.98 | 8.81 | 21.49 | 15.38 |